A clear trend in the recent literature and on-going clinical trials can be envisaged, that is the development of miRNA-based noninvasive detection assays using liquid biopsies (mainly blood or serum samples) as starting material to inform clinical decisions, whereas initial diagnostic/prognostic studies used tissues from diagnostic biopsies or surgical procedures.
1
—
—